News|Articles|March 24, 2026

Mississippi man ordered to pay $31M over federal health care referral scheme; NIH’s $150M push to replace animal testing; caffeine may replace memory loss from sleep deprivation – Morning Medical Update

Fact checked by: Keith A. Reynolds
Listen
0:00 / 0:00

Key Takeaways

  • Federal enforcement secured a $31M judgment against Robert L. Crites for Anti-Kickback and False Claims Act violations tied to $5.4M TRICARE losses.
  • NIH committed $150M+ to Complement-ARIE, advancing organ-on-chip, lab-grown systems, computational models, and validation infrastructure to standardize human-relevant methods for regulatory uptake.
SHOW MORE

The top news stories in medicine today.

Mississippi man hit with $31M judgement in TRICARE kickback scheme

A Mississippi man has been ordered to pay more than $31 million for his role in a nationwide health care kickback scheme that targeted federal programs, including TRICARE. According to federal prosecutors, Robert L. Crites orchestrated a referral network that steered patients — particularly military beneficiaries — to a pharmacy in Alabama in exchange for illegal commissions. The scheme violated the Anti-Kickback Statute and the False Claims Act, with the judgment including treble damages and civil penalties tied to more than $5.4 million in losses to TRICARE. Officials said the case underscores ongoing efforts to combat health care fraud and protect the integrity of federally funded programs.

NIH launches $150M push to replace animal testing models

The National Institutes of Health (NIH) is investing more than $150 million to develop human-based research models aimed at reducing reliance on animal testing and improving how diseases are studied. The new Complement-ARIE program will fund technologies such as lab-grown systems, organ-on-chip platforms and computational models that better replicate human biology, with applications spanning cardiac, neurological, rare and gynecological diseases. The initiative also includes a national data hub, validation network and public-private partnerships to help standardize and scale these methods for regulatory use. Officials say the effort could improve the accuracy of drug development and accelerate clinical translation by shifting toward more predictive, human-relevant research tools.

Caffeine may reverse memory loss from sleep deprivation

New research from the National University of Singapore suggests caffeine can restore memory function impaired by sleep deprivation by targeting specific brain pathways. In a study published in Neuropsychopharmacology, researchers found that sleep loss disrupted synaptic activity in the hippocampus, a region critical for memory, leading to deficits in social recognition. However, caffeine intake restored normal neural communication and reversed these memory impairments without overstimulating the brain. The findings highlight caffeine’s potential to selectively repair cognitive function affected by sleep loss and could inform future therapies aimed at mitigating sleep-related cognitive decline.